Omidria approved for pediatric patients

The FDA has expanded the indication for Omidria, a mydriatic and NSAID combination agent, to include use in pediatric patients from birth through 17 years.
Source: Daily Dose of Eye Care

https://www.lvcenter4sight.com/omidria-approved-for-pediatric-patients/

Comments

Popular posts from this blog

The Hidden Perils of Eye Rubbing

Save Your Vision at All Stages in Life

Zeaxanthin and Lutein Save the Eyes and Improve Brain Circulation